Compare YSS & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | YSS | IART |
|---|---|---|
| Founded | 2012 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2025 | 1996 |
| Metric | YSS | IART |
|---|---|---|
| Price | $7.20 | $13.38 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 11 |
| Target Price | $14.85 | ★ $18.38 |
| AVG Volume (30 Days) | ★ 2.5M | 878.2K |
| Earning Date | 11-15-2026 | 10-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1.88 | $1.66 |
| Revenue Next Year | $26.77 | $3.37 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.20 | $8.70 |
| 52 Week High | $44.54 | $20.49 |
| Indicator | YSS | IART |
|---|---|---|
| Relative Strength Index (RSI) | 30.76 | 31.48 |
| Support Level | N/A | $10.42 |
| Resistance Level | $18.95 | $14.12 |
| Average True Range (ATR) | 0.62 | 0.63 |
| MACD | -0.03 | -0.26 |
| Stochastic Oscillator | 5.48 | 22.88 |
York Space Systems Inc is a U.S.-based space and defense company that provides mission-related solutions for national security, government, and commercial customers. The company develops its own hardware and software, offering capabilities intended to support customer requirements across various elements of the space mission lifecycle. It offers mission solutions across several complementary product categories: Components, Subsystems, Spacecraft Platforms, Ground Operation, Global Downlink, and Software-Enabled Services. The company derives the majority of revenue from long-term firm-fixed-price (FFP) production contracts for the design of small satellites, launch services, and ground services with both U.S. federal government-controlled agencies and domestic commercial customers.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.